Healthcare Industry News: shingles
News Release - April 6, 2010
Wound Management Technologies, Inc. Expands Sales Management to Address Rapid National and International Business DevelopmentFORT WORTH, Texas, April 6 (Healthcare Sales & Marketing Network) -- Wound Management Technologies, Inc. (OTC Bulletin Board:WNDM.ob ) announced today that its subsidiary Wound Care Innovations, LLC has expanded its sales management team with the addition of two highly experienced executives. As WCI's newly appointed Senior Vice President of Marketing and Sales Ron Mathis brings over 30 years of marketing and sales experience in a variety of industries including software systems and most recently medical device and pharmaceutical manufacturing. His background includes extensive experience in both the commercial and government sectors where he not only leveraged his sales and marketing expertise but also provided critical project management guidance. Mr. Mathis will be responsible for all associated activities related to the direct sales organization and the interface and coordination of the marketing department. "All of us at Wound Management are very excited to have someone with Ron's experience and track record on our team. This will prove to be a key ingredient in the company's ability to execute the very aggressive business expansion plans we have for the rest of this year," stated Deborah Jenkins Hutchinson, WNDM President. "Additionally, the inclusion of the Distribution sales channel will provide both National and International coordination for our products within the full spectrum of the company and will help to effectively manage the growth of our business," continued Hutchinson.
Also joining WCI will be Zach Guthrie as the newly appointed Vice President of Distribution where he will be responsible for identifying and developing new sales distribution channels for WCI both in the United States and internationally. Mr. Guthrie is a seasoned business development specialist in both the technology and healthcare industries. His most recent experience included operations management of a company that developed regulatory consulting solutions for medical device manufacturers seeking the establishment of sales and distribution in the European Union.
Cathy Bradshaw, President of Wound Care Innovations was quoted as saying, "Ron and Zach are proven professionals in their respective fields. They are a vital component of our team and I look forward to working with them in the marketing and sales of our advanced wound care collagen product, CellerateRx®."
For Wound Management Technologies Shareholder Information please call 817-820-7077 or go to http://www.wmgtech.com
About Wound Care Innovations, LLC
Wound Care Innovations, LLC (WCI) is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTC Bulletin Board:WNDM.ob ) with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida. WCI markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on CellerateRx, please visit the WCI web site at www.Celleraterx.com .
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc.'s primary focus is the distribution of its unique, patented collagen product, CellerateRX®, in the $3.2B worldwide advanced wound care market, a market that is growing due to aging populations and the increase of diabetes. Over the past 2 years WMT has focused on developing evidenced-based studies on CellerateRX and gaining physician awareness by participation in key industry conferences. Now WMT is focused on expanding sales through partnerships and contracted independent representatives. WMT has other advanced biotech products in development for bone wax, bone void fillers and shingles pain reduction as well as a subsidiary focused on eHealth technology for secure healthcare data collaboration and storage. More information can be found on the company's web sites: www.wmgtech.com, www.CellerateRX.com , and www.SecureeHealth.com .
Safe Harbor Statement:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
Source: Wound Management Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.